Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
63.65 -0.65 / -1.01%
As of 4:24pm ET
Day’s Change
During After-Hours   Switch to standard view »
63.44 -0.21 / -0.33%
Volume: 7.3K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-13.52% 3 years+26.49%
3 months-24.16% 5 years+26.44%
1 year+23.11% Since inception+15.29%
Data through 10/07/2015

Quote Details

Previous close$64.30
Open day’s range61.38 – 64.25
Net asset value (NAV)63.17 (10/06/2015)
Daily volume6,393,057
Average volume (3 months)4,925,708
Data as of 4:24pm ET, 10/08/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+26.44%+20.45%
Expense Gross exp ratio0.35%0.46%
Risk 5 year sharpe ratio1.011.31
Net assets$2.1B$1.7B
Average market cap$2.0B$33.2B
Average P/E--24.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RDUS Radius Health Inc1.26%
JUNO Juno Therapeutics Inc1.21%
MYGN Myriad Genetics Inc1.21%
INFI Infinity Pharmaceuticals Inc1.19%
MDXG MiMedx Group Inc1.18%
EXEL Exelixis Inc1.18%
BIIB Biogen1.15%
EXAS Exact Sciences Corp1.14%
ABBV AbbVie1.14%
ALXN Alexion Pharmaceuticals Inc1.13%

Partner Offers